BRS1 - Neurotransmitter Regulation
(Neurotransmitter Signalling & Chemical Communication)
Ambition
Maintain continuous, balanced neurotransmitter signalling across monoaminergic, cholinergic, membrane-lipid, and GABA–glutamate systems so the brain sustains attention, arousal, motivation, emotional regulation, and behavioural control without drifting into depletion, imbalance, or excitation–inhibition mismatch.
Therapeutic Area Research
ADHD is the first fully mapped therapeutic area within the BRAIN Framework, providing a proof of concept for an adaptive biological architecture linking nutrition, biology and function. The same framework is designed to expand across additional therapeutic areas through the shared Phenome Registry.
Introduction
Many brain-related disorders involve altered neurotransmitter signalling, yet no single transmitter fully explains cognitive, emotional or behavioural function. Monoaminergic, cholinergic, membrane-lipid and excitatory–inhibitory pathways jointly shape attention, motivation, arousal and behavioural control.
Dietary proteins, amino-acid quality, meal composition, choline supply, omega-3 membrane biology and cofactor sufficiency all influence whether precursor pools, transport competition and receptor environments remain adequate for stable neurotransmitter signalling under sustained attention demand.
ADHD: Neurotransmitter Regulation Context
In ADHD, neurobiology spans multiple transmitter systems rather than a single deficit. Dopaminergic dysfunction is consistently linked, but evidence does not support a simple global hypo-dopaminergic model—alterations vary by subtype, developmental stage, and brain region, interacting with noradrenergic, serotonergic, cholinergic, glutamatergic, and GABAergic systems.
Meal-level amino-acid sufficiency, LAT1 competitive transport, noradrenergic executive modulation, serotonergic emotional regulation, cholinergic substrate support, neuronal DHA incorporation, and GABA–glutamate balance each represent diet-actionable entry points within BRS1. Emotional dysregulation—frequently co-occurring with ADHD symptom patterns—may further intersect monoaminergic biology without reducing the phenotype to a single transmitter.
ADHD evidence and connected BRS1 mechanisms
| Evidence | Citation | Connected mechanisms |
|---|---|---|
| Dopaminergic dysfunction in ADHD does not support a simple global hypo-dopaminergic model; alterations vary by subtype, stage, and brain region | MacDonald et al., 2024 | BRS1(FM1), BRS1-FM1-PM3 |
| Meal-level amino-acid sufficiency may support catecholaminergic and serotonergic precursor pools relevant to ADHD attention pathways | Wang et al., 2019 | BRS1-FM1-PM1 |
| Tyrosine availability explored in attention-deficit contexts | Reimherr & Ward, 1987 | BRS1-FM1-PM1 |
| Role of serotonin in ADHD | Oades, 2010 | BRS1-FM1-PM4, BRS1-FM1-PM1 |
| Serotonin deficit susceptibility in ADHD | Banerjee and Nandagopal, 2015 | BRS1-FM1-PM4, PH003 — Emotional Regulation |
| Emotion dysregulation in attention deficit hyperactivity disorder | Shaw et al., 2014 | BRS1-FM1-PM4, PH003 — Emotional Regulation |
| Low choline intakes and altered choline status in neurodevelopmental subgroups relevant to attention and learning | Derbyshire et al., 2023 | BRS1(FM2), BRS1-FM2-PM5 |
| Decreased muscarinic acetylcholine receptor binding in neurodevelopmental contexts | Johansson et al., 2013 | BRS1(FM2), BRS1-FM2-PM5 |
| Focus on omega-3 polyunsaturated fatty acids and ADHD | Pei-Chen Chang, 2021 | BRS1(FM3), BRS1-FM3-PM6 |
| PUFA, magnesium, and zinc supplementation studied in children seeking medical attention for behavioural symptoms | Huss et al., 2010 | BRS1(FM3), BRS1-FM3-PM6 |
| Low glutamate in critical brain areas correlates with low Barkley attention scale scores | Maltezos et al., 2014 | BRS1(FM4), BRS1-FM4-PM7 |
| Reduced GABA concentration in attention-deficit/hyperactivity disorder | Edden et al., 2012 | BRS1(FM4), BRS1-FM4-PM7 |
| Reduced striatal GABA in unmedicated children with ADHD | Puts et al., 2020 | BRS1(FM4), BRS1-FM4-PM7, PH015 — Stress Reactivity |
| Neural excitation and inhibition balance framing | Mamiya et al., 2021 | BRS1(FM4), BRS1-FM4-PM10 |
Dietary and Lifestyle Levers
Stable neurotransmitter signalling needs more than precursor supply. Shared amino-acid pools, dietary patterns and lifestyle collectively determine how effectively neurotransmitter systems can synthesise, regulate and sustain signalling across changing cognitive and physiological demands.
The following dietary guidance summarises the principal dietary patterns, shared nutrient pools and representative food sources that support the biological constraints underlying BRS1. The guidance reflects shared biological principles rather than prescriptive recommendations; individual requirements and optimal dietary patterns will vary according to physiology, health status and the wider diet.
Pattern → Nutrients → Biology → Target Foods
Key Constraints of BRS1
Amino-Acid Precursors — KC1: Amino Acid Quality & Competitive Balance
Distribute high-quality protein across the day → tryptophan, phenylalanine and tyrosine → the brain cannot store neurotransmitter precursors and therefore depends on a continuous meal-level supply to maintain monoaminergic synthesis.
Target foods: Eggs • Salmon • Greek Yogurt • Lentils • Tofu. KC: BRS1(KC1). BRS: BRS1-FM1-PM1 BRS1-FM1-PM2 BRS1-FM1-PM3 BRS1-FM1-PM4
Eat a variety of protein sources rather than relying on a single food → complementary indispensable amino-acid profiles → single-source reliance can leave the shared precursor pool incomplete; combining protein sources across meals covers the indispensable set.
Target foods: Lentils • Eggs • Quinoa • Tofu • Tempeh. KC: BRS1(KC1). BRS: BRS1-FM1-PM1 BRS1-FM4-PM8
Protein quality: Plant protein sources may be combined across meals to provide complementary indispensable amino-acid profiles — see relevant Food Profiles for EAA pairing guidance where applicable.
Additional Mechanism-Specific Dietary Levers
Maintain regular meal timing and circadian-aligned eating → amino-acid precursors and meal-level competitive transport context → steady supply of neurotransmitter building blocks across the day supports monoaminergic, cholinergic and excitatory–inhibitory signalling; irregular meal spacing leaves precursor availability and LAT1 competition poorly timed relative to demand.
Target foods: Eggs • Salmon • Greek Yogurt • Lentils • Chicken. BRS: BRS1-FM1-PM1 BRS1-FM1-PM2 BRS1-FM1-PM3 BRS1-FM1-PM4 BRS1-FM2-PM5 BRS1-FM4-PM10 BRS1-FM4-PM7 BRS1-FM4-PM8 BRS1-FM4-PM9
Include choline-rich foods regularly → choline and phospholipids → acetylcholine production and neuronal membrane structure draw on dietary choline supply; low intake constrains cholinergic substrate availability.
Target foods: Eggs • Soy • Tofu • Tempeh • Edamame. BRS: BRS1-FM2-PM5 BRS1-FM3-PM6
Include omega-3-rich foods regularly → DHA, EPA and membrane-supportive phospholipids → neuronal membrane composition and receptor environments depend on long-chain omega-3 supply; low intake constrains membrane fluidity and signalling efficiency.
Target foods: Salmon • Fish Roe • Algae • Walnuts • Flax Seeds. BRS: BRS1-FM3-PM6 BRS1-FM4-PM10
Omega-3: Marine foods and microalgae provide preformed DHA and EPA. Walnuts and flax provide ALA, which requires endogenous conversion with variable efficiency.
Maintain dietary variety across nutrient-dense whole foods → vitamins B6, B9 and B12, iron, zinc and magnesium → neurotransmitter synthesis, conversion and regulation need these cofactors; narrow dietary variety leaves enzyme support under-provided.
Target foods: Pumpkin Seeds • Eggs • Spinach • Nutritional Yeast • Fortified Plant Milks. BRS: BRS1-FM4-PM7 BRS1-FM4-PM8
Vitamin B12: Vegan dietary patterns should obtain vitamin B12 from fortified foods and/or supplementation where appropriate.
Include polyphenol-rich plant foods and healthy fats → polyphenols and monounsaturated fats → supports glutamate clearance, GABA synthesis capacity and healthier excitatory–inhibitory regulation when plant and fat variety is narrow.
Target foods: Blueberries • Extra Virgin Olive Oil • Walnuts • Spinach • Greek Yogurt. BRS: BRS1-FM4-PM8 BRS1-FM4-PM9 BRS1-FM4-PM10
Targeted interventions that may enhance biological system performance beyond foundational dietary guidance and lifestyle priorities. They complement — rather than replace — Key Constraints, Dietary Guidance and Lifestyle Priorities.
Optimising food structure, cooking, bioavailability and nutrient delivery.
Prepare omega-3-rich foods gently and include them regularly to protect delicate marine fats during cooking and support ongoing brain membrane health over time.
Supports: BRS1-FM3-PM6 BRS1-FM4-PM7 BRS1-FM4-PM10 BRS1-FM1-PM3
Prefer gentler cooking and stable fat handling to limit avoidable AGE/ALE and oxidised-lipid load that can degrade amino-acid usability and add exogenous oxidative pressure on signalling biology.
Supports: BRS1-FM1-PM2 BRS1-FM4-PM9
Soak or sprout phytate-rich seeds and legumes when mineral density matters to improve plant zinc and mineral bioavailability that supports neurotransmission cofactor chemistry.
Supports: BRS1-FM4-PM7 BRS1-FM4-PM8 BRS1-FM2-PM5
Pair iron-containing foods with vitamin C and meal-context enhancers to improve iron absorption for catecholamine-related cofactor biology.
Supports: BRS1-FM1-PM3
Evidence-informed supplements used under selected physiological or clinical conditions — populated from KC Emerging Biological Supports when present.
Coming soon
Targeted dietary approaches that modify physiology beyond routine healthy eating.
Coming soon
Practices that support circadian entrainment and biological timing.
Coming soon
Practices that deliberately influence autonomic function, adaptive stress responses and physiological resilience.
Coming soon
Prioritise sufficient, consistent sleep to support balanced neurotransmitter regulation, cognitive performance, and physiological recovery.
Supports: BRS1-FM1-PM4
Practise regular stress-management techniques to help maintain healthy stress recovery, balanced autonomic activity, and adaptive neurochemical signalling.
Supports: BRS1-FM1-PM2 BRS1-FM1-PM3 BRS1-FM1-PM4 BRS1-FM2-PM5 BRS1-FM4-PM10 BRS1-FM4-PM7 BRS1-FM4-PM8 BRS1-FM4-PM9
Engage in regular physical activity to support healthy neurotransmitter function, metabolic regulation, and long-term brain resilience.
Supports: BRS1-FM1-PM2 BRS1-FM1-PM3 BRS1-FM1-PM4 BRS1-FM2-PM5 BRS1-FM4-PM10 BRS1-FM4-PM7 BRS1-FM4-PM8 BRS1-FM4-PM9
Functional Mechanisms
Monoaminergic, cholinergic, membrane-lipid, and GABA–glutamate mechanisms jointly govern attention, drive, memory, and excitatory–inhibitory balance. Together they set whether precursor supply, receptor environments, and daily signalling tone can support stable function as demand and circadian timing shift.
- BRS1-FM1-PM1 — Amino-Acid Availability & Prioritisation
- BRS1-FM1-PM2 — LAT1 Competitive Transport Modulation
- BRS1-FM1-PM3 — Noradrenergic Signalling
- BRS1-FM1-PM4 — Serotonergic Signalling Regulation
Maintains monoaminergic signalling capacity by coordinating amino-acid precursor availability, LNAA transport balance, and noradrenergic-serotonergic regulation.
FM page: BRS1(FM1) — Monoaminergic Function
Primary biological effects: ↑ precursor availability; ↑ tyrosine/tryptophan support; improved monoaminergic brain-delivery context
Modulation context: Intervention: Food-State Leaning · Timing-specific: Yes · Coverage: Meal–Daily
Key constraints:
Connected mechanisms:
- BRS2(FM1) — Methylation Cycle Efficiency — bRS2(FM1) — Methylation Cycle Efficiency context relevant to this mechanism
Maintains cholinergic signalling capacity to support attention, working memory, and learning-focused cognitive precision.
FM page: BRS1(FM2) — Cholinergic Function
Primary biological effects: ↑ choline availability; ↑ acetylcholine synthesis support; ↑ cholinergic signalling context
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Meal–Daily
Connected mechanisms:
- BRS1-FM1-PM1 - Amino-Acid Availability & Prioritisation — fM1-PM1 - Amino-Acid Availability & Prioritisation context relevant to this mechanism
- BRS1-FM1-PM2 - LAT1 Competitive Transport Modulation — fM1-PM2 - LAT1 Competitive Transport Modulation context relevant to this mechanism
- BRS2(FM1) — Methylation Cycle Efficiency — bRS2(FM1) — Methylation Cycle Efficiency context relevant to this mechanism
Maintains neuronal membrane DHA integration and phospholipid-mediated omega-3 delivery to support stable signalling and membrane integrity.
FM page: BRS1(FM3) — Membrane Composition, Fluidity & Structural Lipid Integrity
Primary biological effects: ↑ membrane fluidity context; ↑ structural lipid integrity; ↑ neuronal signalling competence
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily–Weekly
Connected mechanisms:
- BRS1-FM1-PM1 — fM1-PM1 context relevant to this mechanism
- BRS1-FM1-PM2 — fM1-PM2 context relevant to this mechanism
- BRS1-FM2-PM5 - Acetylcholine Synthesis Support — phospholipid context is listed in section 7.2
- BRS3-FM2-PM5 - Lipid Peroxidation Control — membrane PUFA protection once DHA is incorporated
- BRS3-FM3-PM8 - Eicosanoid / SPM Balance — downstream lipid-mediator context from membrane fatty-acid pools
- BRS1-FM4-PM7 — GABA–Glutamate Neurotransmission Balance
- BRS1-FM4-PM8 — GABA Synthesis Capacity
- BRS1-FM4-PM9 — Glutamate Clearance & Recycling
- BRS1-FM4-PM10 — Excitotoxicity Modulation
Maintains excitatory-inhibitory balance by coordinating glutamatergic drive and GABAergic inhibition to support neural stability.
FM page: BRS1(FM4) — GABA–Glutamate Regulation
Primary biological effects: ↑ inhibitory tone support; ↑ GABA synthesis support; ↑ glutamate control; ↑ excitation–inhibition balance
Modulation context: Intervention: Food-State Leaning · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS1-FM1-PM1 — provides meal-level amino-acid substrate context for glutamate precursor pools
- BRS3-FM1-PM1 — NF-kB Signalling Regulation — Inflammatory Tone Regulation
- BRS4-FM1-PM1 — Electron Transport Chain Function — Mitochondrial Bioenergetic Support
- BRS6-FM1-PM1 — Glucose Appearance Kinetics — Glycaemic Stability
Cross-BRS Dependencies
Neurotransmitter regulation depends upon the coordinated performance of multiple Biological Regulatory Systems rather than a single isolated pathway. Cross-BRS Dependencies describe these systems-level relationships, explaining how upstream adaptive biology shapes the biological environment within which resilient neurotransmitter regulation can be maintained during changing physiological demands.
- (BRS4 → BRS1) Bioenergetic Support for Neurotransmission
- (BRS3 → BRS1) Inflammatory Modulation of Neurotransmitter Systems
- (BRS6 → BRS1) Stress-Axis and Autonomic Shaping of Neurotransmission
- (BRS2 → BRS1) One-Carbon and BH4 Support for Monoamine Biology
- (BRS5 → BRS1) Gut–Vagal Modulation of Neurochemical Signalling
Biological Contribution
Collectively, the Functional Mechanisms within BRS4 maintain the adaptive bioenergetic reserve that enables BRS1 to sustain neurotransmitter regulation under prolonged physiological demand.
Systems Significance
By preserving these bioenergetic capacities, BRS4 reduces the likelihood that energetic limitation becomes the principal rate-limiting constraint on neurotransmitter regulation within BRS1 as allostatic load accumulates. BRS4 is not itself a neurotransmitter system. Instead, it functions as an upstream enabling system that preserves the bioenergetic conditions required for resilient neurotransmitter regulation. Maintaining BRS4 therefore complements neurotransmitter precursor and cofactor biology by preserving adaptive bioenergetic capacity rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS4 maintain energetic reserve, metabolic flexibility, oxidative resilience and adaptive mitochondrial capacity required to sustain neurotransmission during prolonged cognitive, metabolic and physiological demand. Rather than acting through a single pathway, these integrated capacities collectively preserve neuronal energy availability and reduce the likelihood that sustained physiological demand degrades neurotransmitter regulation within BRS1.
Supporting Evidence
Harris et al., 2012 — Demonstrated that synaptic signalling accounts for the largest proportion of neuronal energy expenditure and that sustained neurotransmission depends upon adequate mitochondrial ATP supply during increasing energetic demand.
Picard, 2015 — Reframed mitochondria as dynamic signalling and energetic organelles that coordinate cellular energetics with neuronal activity, supporting the interpretation of BRS4 as an upstream enabling system preserving BRS1 adaptive performance.
Biological Contribution
Collectively, the Functional Mechanisms within BRS3 maintain the adaptive inflammatory and redox resilience required to preserve an immune environment that supports resilient neurotransmitter regulation within BRS1 during prolonged physiological demand.
Systems Significance
By preserving these immune-regulatory capacities, BRS3 functions as an upstream enabling system, reducing the likelihood that inflammatory and oxidative burden progressively constrain neurotransmitter regulation within BRS1 as allostatic load accumulates. Maintaining BRS3 therefore complements neurotransmitter precursor and cofactor biology by preserving the biological environment within which resilient neurotransmitter regulation can be sustained, rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS3 maintain proportionate inflammatory signalling, antioxidant defence, oxidative resilience and active inflammation resolution required to preserve immune and redox stability during prolonged physiological demand. Rather than acting through a single inflammatory pathway, these integrated capacities collectively regulate how immune and oxidative load influences the biological environment within which BRS1 sustains neurotransmitter regulation.
Supporting Evidence
Slavich & Irwin, 2014 — Established that psychological and physiological stressors activate inflammatory signalling capable of reshaping central nervous system function through coordinated immune, neuroendocrine and neurochemical pathways. This supports the framework interpretation that chronic inflammatory activation can become a principal upstream constraint on BRS1 performance during sustained physiological demand.
Savitz, 2019 — Demonstrated that immune activation reshapes neurotransmitter regulation through the kynurenine pathway and broader neuroimmune interactions, influencing both monoaminergic signalling and excitation–inhibition balance. This supports the BRAIN Framework interpretation that maintaining immune regulation preserves the biological environment required for resilient monoaminergic and excitation–inhibition regulation within BRS1.
Biological Contribution
Collectively, the Functional Mechanisms within BRS6 maintain adaptive neuroendocrine coordination and metabolic stability that enables BRS1 to sustain neurotransmitter regulation under prolonged physiological demand.
Systems Significance
By preserving these whole-body regulatory capacities, BRS6 functions as the principal gateway through which neuroendocrine and metabolic resources are allocated across the integrated Biological Regulatory System network. When adaptive regulation becomes prolonged or dysregulated, this coordinated resource allocation progressively manifests as allostatic load across the wider BRS network. This reduces the likelihood that chronic neuroendocrine activation progressively constrains neurotransmitter regulation within BRS1 as allostatic load accumulates. BRS6 is not itself a neurotransmitter system; it coordinates the resource-allocation logic through which other Biological Regulatory Systems — including BRS1 — sustain resilient performance under demand. Maintaining BRS6 therefore complements neurotransmitter precursor and cofactor biology by preserving the systemic regulatory environment within which resilient neurotransmitter regulation can be sustained, rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS6 coordinate glycaemic regulation, HPA-axis rhythm, autonomic balance and stress-responsive metabolic allocation, continuously adjusting physiological resource distribution to meet changing environmental and cognitive demands. When these regulatory capacities remain proportionate, they help preserve adaptive performance across the wider BRS network. When they become chronically activated or poorly resolved, increasing allostatic load progressively constrains the performance of interconnected Biological Regulatory Systems.
Supporting Evidence
McEwen, 1998 — Established allostatic load as cumulative biological wear arising when stress mediators protect or damage brain structure and function under sustained adaptive demand — supporting the framework interpretation that dysregulated neuroendocrine load may become a principal constraint on BRS1 performance.
McEwen, 2006 — Positioned the brain as the central interpreter and target of stress-mediated adaptive regulation — supporting the framework interpretation that BRS6 coordinates how allostatic load is allocated across integrated biological systems including neurotransmitter regulation within BRS1.
Thayer et al., 2012 — Demonstrated intimate coupling between autonomic regulatory capacity, stress neurobiology and central nervous system function — supporting the interpretation of BRS6 autonomic stability as an upstream enabler of BRS1 adaptive performance during sustained physiological demand.
Biological Contribution
Collectively, the Functional Mechanisms within BRS2 maintain adaptive methyl-donor and cofactor capacity that enables BRS1 to sustain neurotransmitter regulation under prolonged physiological demand.
Systems Significance
By preserving these one-carbon metabolic capacities, BRS2 functions as an upstream enabling system, reducing the likelihood that methyl-donor or cofactor insufficiency progressively limits monoamine synthesis and wider neurotransmitter regulation within BRS1 as metabolic demand intensifies. Maintaining BRS2 therefore complements neurotransmitter precursor availability by preserving the biological environment within which resilient neurochemical regulation can be sustained, rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS2 maintain methylation cycle efficiency, transsulfuration-linked redox coupling and methylation–membrane integrity required to sustain methyl-donor reserves, cofactor chemistry and membrane-related neurochemical support during prolonged physiological demand. Rather than acting through a single biosynthetic step, these integrated capacities collectively preserve the cofactor and methylation context required for stable neurotransmitter regulation within BRS1.
Supporting Evidence
Fanet et al., 2021 — Established that essential cofactor chemistry underpins central monoamine synthesis and neurotransmitter-regulatory capacity — supporting the framework interpretation that BRS2 cofactor reserves may become a principal rate-limiting constraint on monoaminergic regulation when one-carbon metabolism is strained.
Kennedy, 2016 — Demonstrated that B-vitamin-dependent one-carbon metabolism supports brain neurochemical synthesis — supporting the interpretation of BRS2 as an upstream enabling system preserving BRS1 adaptive performance during sustained physiological demand.
Biological Contribution
Collectively, the Functional Mechanisms within BRS5 maintain adaptive gut–brain interface resilience that enables BRS1 to sustain neurotransmitter regulation under prolonged physiological demand.
Systems Significance
By preserving these gut–brain interface capacities, BRS5 functions as an upstream enabling system, reducing the likelihood that impaired gut-derived signalling or substrate availability progressively constrains neurochemical regulation within BRS1 as peripheral immune or metabolic load accumulates. Maintaining BRS5 therefore complements neurotransmitter precursor and cofactor biology by preserving the biological environment within which resilient neurotransmitter regulation can be sustained, rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS5 maintain gut barrier integrity, microbial metabolite signalling capacity and gut–vagal neuromodulation required to preserve stable peripheral-to-central signalling during prolonged physiological demand. Rather than acting through a single gut–brain pathway, these integrated capacities collectively regulate how host–microbial signalling shapes the biological environment within which BRS1 sustains neurotransmitter regulation.
Supporting Evidence
Bravo et al., 2011 — Demonstrated that gut microbiota can modulate central neurochemical regulation through vagal signalling pathways — supporting the framework interpretation that impaired gut–brain communication may become a principal constraint on neurotransmitter regulation during sustained peripheral perturbation.
Jaggar et al., 2020 — Synthesised how microbial metabolite and vagal signalling interact with central nervous system function — supporting the interpretation of BRS5 as an upstream enabling system preserving BRS1 adaptive performance during sustained physiological demand.
Specific Mechanisms
Specific Mechanisms (SMs) are interpretation layers — context-specific readings of stable BRS1 biology grounded in connected PMs, FMs, and KCs. They provide additional biological context for applying the BRAIN Framework. Current SM categories include SM-SNP (genetic variation), SM-CROSS (multi-BRS interpretive concepts), SM-Male and SM-Female (sex-specific biology), SM-Lifestage (e.g. childhood, pregnancy, older adulthood), and SM-Pattern (e.g. vegan, vegetarian, ketogenic). Functional phenotype interpretation is handled via the Phenome Registry rather than SM-PHEN pages. Individual SMs may be combined to create richer biological profiles and support future precision-nutrition applications.